Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02735356 · ClinicalTrials.gov registry record · Early Phase 1
Topical Itraconazole in Treating Patients With Basal Cell Cancer
A Early Phase 1 study, sponsored by Jean Yuh Tang.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT02735356: Completed Early Phase 1 study, sponsored by Jean Yuh Tang.
NCT02735356 is a Early Phase 1 study that has completed, run by Jean Yuh Tang. The registered enrollment target is 9 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02735356, a Early Phase 1 study, has completed, sponsored by Jean Yuh Tang.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
This phase 0 trial studies how well itraconazole gel works in treating patients with basal cell cancer. Itraconazole gel may help to treat basal cell tumors in patients.
Primary Outcome
will be assessed as relative GLi1 mRNA expression
Interventions
- OTHER Placebo
- DRUG Itraconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2016-05-05 |
| Est. Completion | 2017-10-10 |
| Phase | Early Phase 1 |
What the finished NCT02735356 record still lists
NCT02735356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02735356 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02735356 about?
NCT02735356 is a clinical study titled "Topical Itraconazole in Treating Patients With Basal Cell Cancer". This phase 0 trial studies how well itraconazole gel works in treating patients with basal cell cancer. Itraconazole gel may help to treat basal cell tumors in patients.
What is the current status of trial NCT02735356?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2016-05-05. Estimated completion is 2017-10-10.
What interventions are being tested in trial NCT02735356?
The interventions under investigation include: Placebo (OTHER), Itraconazole (DRUG).
Who is sponsoring clinical trial NCT02735356?
This trial is sponsored by Jean Yuh Tang, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02735356's enrollment target sits among peer trials
9 1746th of 2000 higher than 219 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI